GoodRx Holdings, Inc. (GDRX) FY2026 Q2 Balance Sheet

Balance Sheet

As of 2026-06-30

Swipe to see the full flow
GoodRx Holdings, Inc. (GDRX) FY2026 Q2 Balance SheetBalance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.Current liabilities$1.16 BCurrent assets$1.60 BLiabilities$1.70 BAssets$2.34 BNon-current liabilities$537.46 MEquity$647.60 MGross equity(calculated)$2.05 BNon-current assets$743.60 MHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSPrescription reimbursement assetsCash and cash equivalentsAccounts receivable, netPrepaid expenses and other current assetsGoodwillCapitalized software, netIntangible assets, netDeferred tax assets, netOther assetsOperating lease right-of-use assets, netProperty and equipment, netPrescription reimbursement liabilitiesAccrued expenses and other current liabilitiesAccounts payableOperating lease liabilities, currentCurrent portion of debtDebt, netOperating lease liabilities, net of current portionOther liabilitiesAdditional paid-in capitalCommon stock, $0.0001 par value; Class A: 2,000,000 shares authorized, 106,164 and 107,088 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively; and Class B: 1,000,000 shares authorized, 233,964 shares issued and outstanding at June 30, 2026 and December 31, 2025Current assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesEquityGross equity (calculated)Accumulated deficitCurrent liabilitiesCurrent liabilities$1.16 BPrescription reimbursement liabilitiesPrescription reimbursement liabilities$1.04 BCurrent assetsCurrent assets$1.60 BLiabilitiesLiabilities$1.70 BAccrued expenses and other current liabilitiesAccrued expenses and other current liabilities$98.61 MPrescription reimbursement assetsPrescription reimbursement assets$1.08 BAccounts payableAccounts payable$8.91 MAssetsAssets$2.34 BOperating lease liabilities, currentOperating lease liabilities, current$5.36 MCash and cash equivalentsCash and cash equivalents$296.11 MCurrent portion of debtCurrent portion of debt$5.00 MAccounts receivable, netAccounts receivable, net$182.14 MNon-current liabilitiesNon-current liabilities$537.46 MPrepaid expenses and other current assetsPrepaid expenses and other current assets$45.06 MDebt, netDebt, net$481.59 MEquityEquity$647.60 MOperating lease liabilities, net of current portionOperating lease liabilities, net of current portion$47.00 MGoodwillGoodwill$430.33 MOther liabilitiesOther liabilities$8.87 MGross equity (calculated)Gross equity(calculated)$2.05 BNon-current assetsNon-current assets$743.60 MCapitalized software, netCapitalized software, net$140.30 MIntangible assets, netIntangible assets, net$58.25 MDeferred tax assets, netDeferred tax assets, net$47.34 MOther assetsOther assets$28.24 MAdditional paid-in capitalAdditional paid-in capital$2.05 BOperating lease right-of-use assets, netOperating lease right-of-use assets, net$27.63 MProperty and equipment, netProperty and equipment, net$11.51 MCommon stock, $0.0001 par value; Class A: 2,000,000 shares authorized, 106,164 and 107,088 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively; and Class B: 1,000,000 shares authorized, 233,964 shares issued and outstanding at June 30, 2026 and December 31, 2025Common stock$34.00 KAccumulated deficitAccumulated deficit−$1.40 B
Chart details

GoodRx Holdings, Inc. (GDRX) FY2026 Q2 Balance Sheet

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

Assets
2,342,928,000 US dollars
Current assets
1,599,327,000 US dollars
Non-current assets
743,601,000 US dollars
Liabilities
1,695,327,000 US dollars
Current liabilities
1,157,869,000 US dollars
Non-current liabilities
537,458,000 US dollars
Equity
647,601,000 US dollars
Prescription reimbursement assets
1,076,012,000 US dollars
Cash and cash equivalents
296,113,000 US dollars
Accounts receivable, net
182,140,000 US dollars
Prepaid expenses and other current assets
45,062,000 US dollars
Goodwill
430,331,000 US dollars
Capitalized software, net
140,300,000 US dollars
Intangible assets, net
58,254,000 US dollars
Deferred tax assets, net
47,335,000 US dollars
Other assets
28,237,000 US dollars
Operating lease right-of-use assets, net
27,630,000 US dollars
Property and equipment, net
11,514,000 US dollars
Prescription reimbursement liabilities
1,039,995,000 US dollars
Accrued expenses and other current liabilities
98,610,000 US dollars
Accounts payable
8,906,000 US dollars
Operating lease liabilities, current
5,358,000 US dollars
Current portion of debt
5,000,000 US dollars
Debt, net
481,588,000 US dollars
Operating lease liabilities, net of current portion
47,004,000 US dollars
Other liabilities
8,866,000 US dollars
Additional paid-in capital
2,048,436,000 US dollars
Common stock, $0.0001 par value; Class A: 2,000,000 shares authorized, 106,164 and 107,088 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively; and Class B: 1,000,000 shares authorized, 233,964 shares issued and outstanding at June 30, 2026 and December 31, 2025
34,000 US dollars
Preferred stock, $0.0001 par value; 50,000 shares authorized and nil shares issued and outstanding at June 30, 2026 and December 31, 2025
0 US dollars
Accumulated deficit
negative 1,400,869,000 US dollars
Gross equity (calculated)
2,048,470,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
GoodRx Holdings, Inc. (GDRX) FY2026 Q2 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!